(三)安全性、有效性、价格皆胜于现有竞品,彰显商业价值。 雷诺嗪(Ranexa/Ranolazine)是目前复方丹参滴丸在国际市场上的主要竞争产品,也是FDA在慢性心绞痛领域距离现在最近批准的一款药品,于06年获批上市...
基于152个网页-相关网页
But at least CVT is going to get to give Ranexa one more big push.
FORBES: Magazine Article
Ranexa was tested on top of Norvasc in patients who were already benefiting the most from that drug.
FORBES: A Biotech's Big Comeback
Apart from that, the results might assure doctors that Ranexa does not cause deadly changes in heart rhythm.
FORBES: A Good Failure?
应用推荐
模块上移
模块下移
不移动